CSPC Pharmaceutical Group
$9.93Change from previous close: −1.39%Absolute change: −$0.14
Valuation
Data as of October 3, 2026
Valuation multiples
- Market cap
- $113.26B
- Enterprise value
- $97.29B
- P/E (trailing 12 months)
- 13.1
- Forward P/E
- 14.9
- PEG
- 1.22
- Price/book
- 2.58
- Price/sales
- 3.62
- EV/EBITDA
- 9.86
- EV/revenue
- 3.11
Profitability and growth
- Gross margin
- 71.9%
- Operating margin
- 52.6%
- Net margin
- 23.7%
- ROE
- 20.9%
- ROA
- 10.7%
- Revenue growth (year over year)
- 93.8%
- Earnings growth (year over year)
- 388.4%
Financial health
- Total cash
- $18.42B
- Total debt
- $652.49M
- Debt/equity
- 0.02
- Current ratio
- 2.14
- Quick ratio
- 1.90
Dividends
- Annual dividend per share
- $0.36
- Dividend yield
- 3.6%
- Payout ratio
- 39.7%
- Ex-dividend date
- October 20, 2026
Analysts and estimates
- Average price target
- $12.64
- Median price target
- $12.00
- High price target
- $19.36
- Low price target
- $8.00
- Analysts with a price target
- 23
- Consensus
- Buy
- Forward EPS
- $0.67
- EPS estimate, current year
- $0.89
Shares and trading
- Beta
- 0.76
- Average volume
- 99.43M
- Shares outstanding
- 11.41B
- Float
- 7.63B
- Institutional ownership
- 36.8%
- Insider ownership
- 32.6%